PA8517201A1 - STABLE LIQUID ANTIHISTAMINIC ANTIHISTAMINIC PHARMACEUTICAL COMPOSITIONS - Google Patents

STABLE LIQUID ANTIHISTAMINIC ANTIHISTAMINIC PHARMACEUTICAL COMPOSITIONS

Info

Publication number
PA8517201A1
PA8517201A1 PA20018517201A PA8517201A PA8517201A1 PA 8517201 A1 PA8517201 A1 PA 8517201A1 PA 20018517201 A PA20018517201 A PA 20018517201A PA 8517201 A PA8517201 A PA 8517201A PA 8517201 A1 PA8517201 A1 PA 8517201A1
Authority
PA
Panama
Prior art keywords
antihistaminic
pharmaceutical compositions
stable liquid
stable
pseudoefedrine
Prior art date
Application number
PA20018517201A
Other languages
Spanish (es)
Inventor
Ramos Jose De Jesus Villacampa
Lugo Sergio Rolando Ulloa
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from MXPA/A/2000/005129A external-priority patent/MXPA00005129A/en
Application filed by Schering Corp filed Critical Schering Corp
Publication of PA8517201A1 publication Critical patent/PA8517201A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

SE DESCRIBEN COMPOSICIONES FARMACEUTICAS LIQUIDAS QUE CONTIENEN LORATADINA Y UN ANTICONGESTIVO TAL COMO SULFATO DE PSEUDOEFEDRINA Y POR LO MENOS UN VEHICULO LIQUIDO FARMACEUTICAMENTE ACEPTABLE, LAS CUALES SON ESTABLES A LA DEGRADACION FISICA Y QUIMICA Y A LA CONTAMINACION MICROBIANA.LIQUID PHARMACEUTICAL COMPOSITIONS CONTAINING LORATADINE AND AN ANTI-LONG TEST SUCH AS PSEUDOEFEDRINE SULFATE ARE DESCRIBED AND AT LEAST A PHARMACEUTICALLY ACCEPTABLE LIQUID VEHICLE, WHICH ARE STABLE TO PHYSICAL CHEMICAL AND DEMODIAL DEGRADATION.

PA20018517201A 2000-05-25 2001-05-22 STABLE LIQUID ANTIHISTAMINIC ANTIHISTAMINIC PHARMACEUTICAL COMPOSITIONS PA8517201A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MXPA/A/2000/005129A MXPA00005129A (en) 2000-05-24 Liquid and stable antihistaminic - anti-congestive pharmaceutical compositions

Publications (1)

Publication Number Publication Date
PA8517201A1 true PA8517201A1 (en) 2002-08-26

Family

ID=33308448

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20018517201A PA8517201A1 (en) 2000-05-25 2001-05-22 STABLE LIQUID ANTIHISTAMINIC ANTIHISTAMINIC PHARMACEUTICAL COMPOSITIONS

Country Status (7)

Country Link
AU (1) AU2001264806A1 (en)
BR (1) BR0111018A (en)
CR (1) CR6804A (en)
EC (1) ECSP024356A (en)
PA (1) PA8517201A1 (en)
PE (1) PE20020055A1 (en)
WO (1) WO2001089527A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6635654B1 (en) 2003-01-09 2003-10-21 Allergan, Inc. Ophthalmic compositions containing loratadine
WO2006135254A1 (en) * 2005-06-17 2006-12-21 Aft Pharmaceuticals Limited Novel pharmaceutical composition and its use in a method for treatment of patients with upper respiratory mucosal congestion
AU2007269835A1 (en) * 2006-06-29 2008-01-10 Schering Corporation Sugar-free storage-stable antihistaminic syrups
CN116898799B (en) * 2023-08-30 2024-04-30 哈尔滨圣泰生物制药有限公司 Desloratadine oral preparation and preparation method thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783465A (en) * 1984-04-09 1988-11-08 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
CA2170488A1 (en) * 1993-09-07 1995-03-16 Sekhar Mitra Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive
PL333056A1 (en) * 1996-10-31 1999-11-08 Schering Corp Composition intended to treat asthma, containing loratadin and a hyperaemia reducing drug
US6132758A (en) * 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
US6051585A (en) * 1998-12-07 2000-04-18 Weinstein; Robert E. Single-dose antihistamine/decongestant formulations for treating rhinitis
CA2405238C (en) * 2000-04-14 2014-03-18 J-Med Pharmaceuticals, Inc. Single-dose antihistamine/decongestant formulations for treating rhinitis

Also Published As

Publication number Publication date
WO2001089527A3 (en) 2003-10-16
WO2001089527A2 (en) 2001-11-29
BR0111018A (en) 2004-02-17
AU2001264806A1 (en) 2001-12-03
ECSP024356A (en) 2003-03-31
PE20020055A1 (en) 2002-02-12
CR6804A (en) 2008-10-29

Similar Documents

Publication Publication Date Title
DK1157037T3 (en) G-CSF-conjugates
EA200100519A1 (en) COMPOSITIONS ON THE BASIS OF A FINE-GROUNDED EPLERENON
NO20021450L (en) Cyclic amine compounds as CCR5 antagonists
BR9916585A (en) Ccr5 modulators
MY137535A (en) New pyrrolidinium derivatives
BR0208741A (en) Piperidine Derivatives
BR0012752A (en) Benzofuryl piperazines and benzofuril homopiperazines: serotonin agonists
SE0003449L (en) Cancer-inhibiting compositions
CR9846A (en) 2-AMINO-7,8-DIHIDRO-6H-PIRIDO [4,3-D] PIRIMIDINA-5-ONAS
BRPI9907866B8 (en) pharmaceutical composition, as well as its use
NO20032905L (en) New benzodiazepines and related heterocyclic derivatives useful as orexin receptor antagonists
TR200100054T2 (en) Paroxetine methanesulfonate
ES2165723T3 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING MUPIROCINE.
ECSP066860A (en) ORAL MATRIX FORMULATIONS THAT INCLUDE LICARBAZEPINA
CO5280222A1 (en) PHARMACEUTICAL COMPOSITION THAT PEMETREXED INCLUDES
BR0209440A (en) Sulfonamides
ECSP034860A (en) 5-SUBSTITUTES-2-ARILPIRIDINAS AS MODULATORS OF CORTICOTROPINE RELEASE FACTOR 1
ATE381575T1 (en) MODIFIED BORRELIA BURGDORFERI OSPA
NO20064783L (en) Solution tablets with licarbazepine
PA8517201A1 (en) STABLE LIQUID ANTIHISTAMINIC ANTIHISTAMINIC PHARMACEUTICAL COMPOSITIONS
DE10084344T1 (en) Pharmaceutical composition containing cyclosporin
ATE377068T1 (en) SURFACTANT COMPOSITIONS CONTAINING IMPROVEMENT AGENTS
TW200517117A (en) Stabilized compositions containing an oxygen-labile active agent
SE9904404L (en) New composition
BR0116205A (en) Antimicrobial 2-pyridones, their compositions and uses